ZOFRAN IS AIMED AT ANNUAL MARKET OF 2.5 MIL. SCRIPTS FOR CHEMOTHERAPY INDICATION, POST-OP INDICATION COULD BE MORE THAN THREE TIMES AS BIG IN U.S.